vs
Alignment Healthcare, Inc.（ALHC）与Roper Technologies（ROP）财务数据对比。点击上方公司名可切换其他公司
Roper Technologies的季度营收约是Alignment Healthcare, Inc.的1.7倍（$2.1B vs $1.2B），Roper Technologies净利率更高（15.8% vs 0.9%，领先14.9%），Roper Technologies同比增速更快（11.3% vs -74.7%），过去两年Alignment Healthcare, Inc.的营收复合增速更高（34.6% vs 10.5%）
Alignment Healthcare是总部位于美国的医疗保健企业，主打联邦医疗保险优势计划，为老年群体提供协调医疗服务、处方药保障及补充福利，采用价值导向医疗模式，与本土医疗机构合作，业务覆盖美国多个州，致力提升患者健康水平。
罗珀技术公司是一家专注于科技领域的控股企业，通过持有并运营多家不同细分赛道的科技公司，在科技产业投资与资产管理领域形成了成熟的业务体系，在全球相关市场具备较高的行业影响力。
ALHC vs ROP — 直观对比
营收规模更大
ROP
是对方的1.7倍
$1.2B
营收增速更快
ROP
高出86.0%
-74.7%
净利率更高
ROP
高出14.9%
0.9%
两年增速更快
ALHC
近两年复合增速
10.5%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.2B | $2.1B |
| 净利润 | $11.4M | $331.0M |
| 毛利率 | — | 69.4% |
| 营业利润率 | — | 27.2% |
| 净利率 | 0.9% | 15.8% |
| 营收同比 | -74.7% | 11.3% |
| 净利润同比 | — | 53.7% |
| 每股收益（稀释后） | — | $4.87 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ALHCROP
| Q1 26 | $1.2B | $2.1B | ||
| Q4 25 | $1.0B | $2.1B | ||
| Q3 25 | $993.7M | $2.0B | ||
| Q2 25 | $1.0B | $1.9B | ||
| Q1 25 | $926.9M | $1.9B | ||
| Q4 24 | $701.2M | $1.9B | ||
| Q3 24 | $692.4M | $1.8B | ||
| Q2 24 | $681.3M | $1.7B |
净利润ALHCROP
| Q1 26 | $11.4M | $331.0M | ||
| Q4 25 | $-11.0M | $428.4M | ||
| Q3 25 | $3.7M | $398.5M | ||
| Q2 25 | $15.7M | $378.3M | ||
| Q1 25 | $-9.1M | $331.1M | ||
| Q4 24 | $-31.1M | $462.3M | ||
| Q3 24 | $-26.4M | $367.9M | ||
| Q2 24 | $-24.0M | $337.1M |
毛利率ALHCROP
| Q1 26 | — | 69.4% | ||
| Q4 25 | — | 69.5% | ||
| Q3 25 | — | 69.5% | ||
| Q2 25 | — | 69.2% | ||
| Q1 25 | — | 68.7% | ||
| Q4 24 | — | 68.3% | ||
| Q3 24 | — | 69.2% | ||
| Q2 24 | — | 69.5% |
营业利润率ALHCROP
| Q1 26 | — | 27.2% | ||
| Q4 25 | -1.0% | 28.6% | ||
| Q3 25 | 0.8% | 28.4% | ||
| Q2 25 | 2.2% | 28.2% | ||
| Q1 25 | -0.6% | 27.9% | ||
| Q4 24 | -3.2% | 28.0% | ||
| Q3 24 | -2.8% | 28.1% | ||
| Q2 24 | -2.7% | 28.8% |
净利率ALHCROP
| Q1 26 | 0.9% | 15.8% | ||
| Q4 25 | -1.1% | 20.8% | ||
| Q3 25 | 0.4% | 19.8% | ||
| Q2 25 | 1.5% | 19.5% | ||
| Q1 25 | -1.0% | 17.6% | ||
| Q4 24 | -4.4% | 24.6% | ||
| Q3 24 | -3.8% | 20.8% | ||
| Q2 24 | -3.5% | 19.6% |
每股收益（稀释后）ALHCROP
| Q1 26 | — | $4.87 | ||
| Q4 25 | $-0.04 | $3.97 | ||
| Q3 25 | $0.02 | $3.68 | ||
| Q2 25 | $0.07 | $3.49 | ||
| Q1 25 | $-0.05 | $3.06 | ||
| Q4 24 | $-0.15 | $4.29 | ||
| Q3 24 | $-0.14 | $3.40 | ||
| Q2 24 | $-0.13 | $3.12 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $705.6M | $382.9M |
| 总债务越低越好 | — | $9.7B |
| 股东权益账面价值 | $206.9M | $18.8B |
| 总资产 | $1.3B | $34.6B |
| 负债/权益比越低杠杆越低 | — | 0.52× |
8季度趋势，按日历期对齐
现金及短期投资ALHCROP
| Q1 26 | $705.6M | $382.9M | ||
| Q4 25 | $604.2M | $297.4M | ||
| Q3 25 | $644.1M | $320.0M | ||
| Q2 25 | $503.8M | $242.4M | ||
| Q1 25 | $479.5M | $372.8M | ||
| Q4 24 | $470.6M | $188.2M | ||
| Q3 24 | $381.0M | $269.6M | ||
| Q2 24 | $363.7M | $251.5M |
总债务ALHCROP
| Q1 26 | — | $9.7B | ||
| Q4 25 | $323.2M | $9.3B | ||
| Q3 25 | $322.7M | — | ||
| Q2 25 | $322.3M | — | ||
| Q1 25 | $321.9M | — | ||
| Q4 24 | $321.4M | $7.6B | ||
| Q3 24 | $212.0M | — | ||
| Q2 24 | $211.7M | — |
股东权益ALHCROP
| Q1 26 | $206.9M | $18.8B | ||
| Q4 25 | $179.3M | $19.9B | ||
| Q3 25 | $161.9M | $20.0B | ||
| Q2 25 | $141.0M | $19.6B | ||
| Q1 25 | $108.1M | $19.2B | ||
| Q4 24 | $99.9M | $18.9B | ||
| Q3 24 | $114.5M | $18.5B | ||
| Q2 24 | $123.7M | $18.1B |
总资产ALHCROP
| Q1 26 | $1.3B | $34.6B | ||
| Q4 25 | $1.1B | $34.6B | ||
| Q3 25 | $1.1B | $34.6B | ||
| Q2 25 | $1.0B | $33.2B | ||
| Q1 25 | $895.6M | $31.4B | ||
| Q4 24 | $782.1M | $31.3B | ||
| Q3 24 | $692.3M | $31.6B | ||
| Q2 24 | $716.3M | $29.8B |
负债/权益比ALHCROP
| Q1 26 | — | 0.52× | ||
| Q4 25 | 1.80× | 0.47× | ||
| Q3 25 | 1.99× | — | ||
| Q2 25 | 2.29× | — | ||
| Q1 25 | 2.98× | — | ||
| Q4 24 | 3.22× | 0.40× | ||
| Q3 24 | 1.85× | — | ||
| Q2 24 | 1.71× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $128.7M | — |
| 自由现金流经营现金流 - 资本支出 | — | $507.0M |
| 自由现金流率自由现金流/营收 | — | 24.2% |
| 资本支出强度资本支出/营收 | — | 0.5% |
| 现金转化率经营现金流/净利润 | 11.27× | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ALHCROP
| Q1 26 | $128.7M | — | ||
| Q4 25 | $-50.4M | $738.0M | ||
| Q3 25 | $144.6M | $869.5M | ||
| Q2 25 | $29.1M | $404.1M | ||
| Q1 25 | $16.6M | $528.7M | ||
| Q4 24 | $-8.7M | $722.2M | ||
| Q3 24 | $26.2M | $755.4M | ||
| Q2 24 | $23.5M | $384.1M |
自由现金流ALHCROP
| Q1 26 | — | $507.0M | ||
| Q4 25 | $-55.4M | — | ||
| Q3 25 | $139.1M | — | ||
| Q2 25 | $21.1M | — | ||
| Q1 25 | $8.4M | — | ||
| Q4 24 | $-18.0M | — | ||
| Q3 24 | $16.9M | — | ||
| Q2 24 | $11.8M | — |
自由现金流率ALHCROP
| Q1 26 | — | 24.2% | ||
| Q4 25 | -5.5% | — | ||
| Q3 25 | 14.0% | — | ||
| Q2 25 | 2.1% | — | ||
| Q1 25 | 0.9% | — | ||
| Q4 24 | -2.6% | — | ||
| Q3 24 | 2.4% | — | ||
| Q2 24 | 1.7% | — |
资本支出强度ALHCROP
| Q1 26 | — | 0.5% | ||
| Q4 25 | 0.5% | — | ||
| Q3 25 | 0.6% | — | ||
| Q2 25 | 0.8% | — | ||
| Q1 25 | 0.9% | — | ||
| Q4 24 | 1.3% | — | ||
| Q3 24 | 1.3% | — | ||
| Q2 24 | 1.7% | — |
现金转化率ALHCROP
| Q1 26 | 11.27× | — | ||
| Q4 25 | — | 1.72× | ||
| Q3 25 | 38.77× | 2.18× | ||
| Q2 25 | 1.86× | 1.07× | ||
| Q1 25 | — | 1.60× | ||
| Q4 24 | — | 1.56× | ||
| Q3 24 | — | 2.05× | ||
| Q2 24 | — | 1.14× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
